The Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia: A Targeted Literature Review With a Focus on Outcomes Relevant to Health Care Decision-Makers in the United States.
Christoph U CorrellPin XiangKaushik SarikondaNikhil BhagvandasMatthew GitlinPublished in: The Journal of clinical psychiatry (2024)
Conclusions: This review highlights the economic burden of cognitive impairment and negative symptoms by focusing on outcomes relevant to health care decision-makers in the United States.